Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter


FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Democrat Chairman Stark Releases Report on Republican Plans for Health Care

Thursday, December 16, 2010

House Ways and Means Health Subcommittee Chairman Pete Stark (D-GA) released a report today titled “Dangerous to America’s Health: The Republican Plan to Dismantle America’s Health Care.”  The Stark report provides insight into the arguments Democrats will make in opposition to Republican attempts to repeal some or all of the “Patient Protection and Affordable Care Act” (PPACA), the new health reform law, in the next Congress. Throughout the report, Chairman Stark focuses on the parts of PPACA that are the most popular with the general public such as eliminating the ability to deny coverage based on a preexisting condition and decreasing the number of uninsured Americans.

With Republicans taking control of the House of Representatives in January, the repeal of PPACA will be at forefront of the legislative agenda in the House. With Democratic control of the Senate and a Democrat in the White House, the odds of repeal of PPACA in the next two years remain highly unlikely.

ASA staff continues monitoring potential legislative changes to PPACA, as well as actively lobbying on key provisions through the regulatory process.

Click here to read Chairman Stark’s report.

« Back to Washington Alerts